Ibiglustat L-Malic acid structure
|
Common Name | Ibiglustat L-Malic acid | ||
|---|---|---|---|---|
| CAS Number | 1629063-78-0 | Molecular Weight | 523.574 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H30FN3O7S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Ibiglustat L-Malic acidIbiglustat L-Malic acid (Venglustat L-Malic acid) is a selective inhibitor of glucosylceramide synthase. |
| Name | Ibiglustat succinate |
|---|---|
| Synonym | More Synonyms |
| Description | Ibiglustat L-Malic acid (Venglustat L-Malic acid) is a selective inhibitor of glucosylceramide synthase. |
|---|---|
| Related Catalog | |
| In Vitro | Ibiglustat (Venglustat) L-Malic acid is a selective inhibitor of glucosylceramide synthase. Ibiglustat is also used in the treatment of Fabry's disease[1]. |
| References |
[1]. WO 2015089067 A1. |
| Molecular Formula | C24H30FN3O7S |
|---|---|
| Molecular Weight | 523.574 |
| Exact Mass | 523.178833 |
| InChIKey | SQXUKOJKIWCALK-AAXLQGCPSA-N |
| SMILES | CC(C)(NC(=O)OC1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1.O=C(O)CC(O)C(=O)O |
| (2S)-2-Hydroxysuccinic acid - (3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]-2-propanyl}carbamate (1:1) |
| VENGLUSTAT L-MALATE |